Inactive Instrument

Other languages Cosmo Pharmaceuticals S.p.A Swiss Exchange

Equities

End-of-day quote Swiss Exchange Other stock markets
- ^CHF	-

03/06	Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down	MT
26/04	Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	CI

Morning Briefing - Markt Schweiz	03/06
Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down	03/06
Cosmo darf definitive Jahresrechnung 2023 bis Ende Mai veröffentlichen	30/04
Cosmo pourra publier ses résultats 2023 définitifs d'ici au 31 mai	30/04
Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	27/04
Cosmo Pharmaceuticals Names New CEO, Chairman	25/04
Changements à la tête de Cosmo	25/04
Cosmo ernennt Giovanni Di Napoli zum neuen CEO - Della Chà wird VR-Präsident	25/04
Cosmo treibt mit dem Partner Medtronic endoskopische Versorgung voran	12/04
Cosmo Pharmaceuticals N.V. Proposes Dividend Payment for 2024	20/03
Cosmo Pharmaceuticals N.V. Provides Earnings Guidance for the Year 2024 and Revenue Guidance for 2025	20/03
Cosmo voit ses revenus reculer en 2023	20/03
Cosmo stellt trotz Gewinnrückgang verdoppelte Dividende in Aussicht	20/03
Cosmo Pharmaceuticals' FY23 Profit, Revenue Drops	20/03
Cosmo Pharmaceuticals N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Bourse Zurich: le SMI finit sous la barre des 11'600 points	19/03
Cosmo: feu vert pour la commercialisation du Winlevi aux antipodes	19/03
Cosmo erhält Zulassung für Winlevi in Australien	19/03
Cosmo Pharmaceuticals Partner Gets Regulatory Approval for Acne Treatment in Australia	19/03
Bourse Zurich: en vert à l'entame d'une "semaine banques centrales"	11/12

No results for this search